Warning: The NCBI web site requires JavaScript to function. more...
The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer.
Hu Z, Huang G, Sadanandam A, Gu S, Lenburg ME, Pai M, Bayani N, Blakely EA, Gray JW, Mao JH.
Breast Cancer Res. 2010;12(2):R18. Epub 2010 Mar 8.
Related citations
DC-SCRIPT: nuclear receptor modulation and prognostic significance in primary breast cancer.
Ansems M, Hontelez S, Looman MW, Karthaus N, Bult P, Bonenkamp JJ, Jansen JH, Sweep FC, Span PN, Adema GJ.
J Natl Cancer Inst. 2010 Jan 6;102(1):54-68. Epub 2009 Dec 14.
Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.
Yau C, Benz CC.
Breast Cancer Res. 2008;10(4):R61. Epub 2008 Jul 17.
Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome.
Witzel ID, Milde-Langosch K, Wirtz RM, Roth C, Ihnen M, Mahner S, Zu Eulenburg C, Jänicke F, Müller V.
J Cancer Res Clin Oncol. 2010 Nov;136(11):1709-18. Epub 2010 Mar 4.
Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features.
Rocha RL, Hilsenbeck SG, Jackson JG, Lee AV, Figueroa JA, Yee D.
J Natl Cancer Inst. 1996 May 1;88(9):601-6.
Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
Urban P, Vuaroqueaux V, Labuhn M, Delorenzi M, Wirapati P, Wight E, Senn HJ, Benz C, Eppenberger U, Eppenberger-Castori S.
J Clin Oncol. 2006 Sep 10;24(26):4245-53.
Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancer.
Davies MP, Barraclough DL, Stewart C, Joyce KA, Eccles RM, Barraclough R, Rudland PS, Sibson DR.
Int J Cancer. 2008 Jul 1;123(1):85-8.
Final Report on Carcinogens Background Document for Styrene.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
HDAC6 expression is correlated with better survival in breast cancer.
Zhang Z, Yamashita H, Toyama T, Sugiura H, Omoto Y, Ando Y, Mita K, Hamaguchi M, Hayashi S, Iwase H.
Clin Cancer Res. 2004 Oct 15;10(20):6962-8.
Final Report on Carcinogens Background Document for Formaldehyde.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.
Habibi G, Leung S, Law JH, Gelmon K, Masoudi H, Turbin D, Pollak M, Nielsen TO, Huntsman D, Dunn SE.
Breast Cancer Res. 2008;10(5):R86. Epub 2008 Oct 16.
Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.
Kobayashi T, Tsuda H, Moriya T, Yamasaki T, Kikuchi R, Ueda S, Omata J, Yamamoto J, Matsubara O.
Breast Cancer Res Treat. 2010 Oct;123(3):733-45. Epub 2009 Dec 18.
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
BMC Cancer. 2007 Apr 12;7:63.
A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA, Robertson KE, Ravel P, Bray SE, Bajard A, Purdie CA, Nguyen C, Hadad SM, Bieche I, Chabaud S, Bachelot T, Thompson AM, Cohen PA.
Breast Cancer Res. 2008;10(5):R88. Epub 2008 Oct 17.
Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH, Cheng YW, Chang JT, Wu TC, Chen CY, Lee H.
Cancer. 2007 Jul 1;110(1):215-23.
Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
Zhang Z, Yamashita H, Toyama T, Yamamoto Y, Kawasoe T, Iwase H.
Clin Cancer Res. 2006 Nov 1;12(21):6410-4.
[Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM, Gao G, Zhang F, Chen H, Wan YF, Li XQ.
Zhonghua Yi Xue Za Zhi. 2006 Oct 24;86(39):2749-55. Chinese.
Expression level of insulin-like growth factor binding protein 5 mRNA is a prognostic factor for breast cancer.
Li X, Cao X, Li X, Zhang W, Feng Y.
Cancer Sci. 2007 Oct;98(10):1592-6. Epub 2007 Jul 25.
Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ, van der Wall E.
Cancer. 2003 Mar 15;97(6):1573-81.
Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.
Adv Exp Med Biol. 2007;608:1-22. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on